Lumexa Imaging Holdings opened lower at $15.71, compared with its previous close of $15.95. In the last trading session, the stock traded between $14.82 and $15.75. It showed a downward intraday trend.
Return calculator
Time Period
An investment of $100 made 1 year ago in Lumexa Imaging Holdings is now worth
$ 80.65
Resulting in a loss of
$ 19.35 (19.35%)
Invest with $1
Note: Past profits do not guarantee future returns.
Lumexa Imaging reported Q3 adjusted EPS of $0.26, beating the $0.18 consensus by 44.44%. Quarterly sales of $271.973 million exceeded the $269.894 million estimate by 0.77%. The company raised its FY26 adjusted EPS guidance to $0.86-$0.90 from $0.71-$0.77. Revenue guidance for FY26 remains unchanged at $1.045 billion-$1.097 billion.
2 days ago
25Aug
Lumexa Imaging schedules four investor conference appearances for September
Lumexa Imaging CEO Caitlin Zulla and CFO Tony Martin to attend four investor conferences in September 2026. Key events include Wells Fargo Healthcare Conference in Boston and JP Morgan High Yield Conference in Nashville. Management will engage in fireside chats and one-on-one meetings with analysts at each venue. Company operated over 190 centers and conducted 4 million procedures in 2025.
2mo ago
13Aug
Lumexa Imaging Q2 2026 revenue up 5.1% to $264.2 million; adj. EPS $0.20
Lumexa Imaging Holdings reported Q2 2026 revenue of $264.2 million, up 5.1% YoY, driven by 6.8% consolidated advanced outpatient volume growth. Adjusted EPS of $0.20 beat estimates by 25%, while GAAP net income turned profitable at $2.7 million. The company narrowed full-year Adjusted EBITDA guidance to $235-$241 million due to $7 million in public company costs but reiterated revenue and EPS targets.
Lumexa Imaging Holdings has revised its FY26 financial outlook, increasing the upper limit of its sales guidance to $1.097 billion from $1.090 billion while keeping the floor at $1.045 billion. Concurrently, the firm reaffirmed its adjusted EPS target of $0.71-$0.77, a figure that stands well above the $0.62 consensus estimate from analysts. The update reflects a slight upward revision in revenue expectations alongside maintained profitability targets that exceed market forecasts.
